(Q37176440)

18 August 2017

1 reference

title

Myocardial repair: from salvage to tissue reconstruction (English)

1 reference

18 August 2017

Emil Ruvinov

1

1 reference

18 August 2017

Tal Dvir

series ordinal

2

1 reference

18 August 2017

Jonathan Leor

series ordinal

3

1 reference

18 August 2017

Smadar Cohen

series ordinal

4

1 reference

18 August 2017

publication date

1 June 2008

1 reference

Expert Review of Cardiovascular Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

6

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

669-686

1 reference

Acute myocardial infarction and heart failure: role of apoptosis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Apoptosis and heart failure: clinical relevance and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocyte apoptosis: programming ventricular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Akt1 in the cardiovascular system: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

The mechanistic basis of infarct healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Inflammatory cytokines and postmyocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

TGFbeta, cardiac fibroblasts, and the fibrotic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Endothelial progenitor cells: new hope for a broken heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Therapeutic myocardial angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

A common progenitor at the heart of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocardial regeneration and stem cell repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocyte death and renewal: modern concepts of cardiac cellular homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Origins and fates of cardiovascular progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Can the cardiomyocyte cell cycle be reprogrammed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Therapeutic opportunities for cell cycle re-entry and cardiac regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

"AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cell therapy in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cell-based therapy of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stem-cell therapy for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Bone marrow cells adopt the cardiomyogenic fate in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Concise review: stem cells, myocardial regeneration, and methodological artifacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Adult stem cells and heart regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Human embryonic stem cell transplantation to repair the infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Signaling factors in stem cell-mediated repair of infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

21 January 2018

Myocardial gene therapy

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene therapy: targeting the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiovascular gene therapy: current status and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Current status of cardiovascular gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Targeting the heart with gene therapy-optimized gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Arteriogenesis Induced by Intramyocardial Vascular Endothelial Growth Factor 165 Gene Transfer in Chronically Ischemic Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Viral-based myocardial gene therapy approaches to alter cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

In vivo gene delivery of HSP70i by adenovirus and adeno-associated virus preserves contractile function in mouse heart following ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cell and gene therapies in cardiovascular disease with special focus on the no option patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene and cell-based therapies for heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Nonviral vector gene modification of stem cells for myocardial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene therapy clinical trials worldwide to 2007--an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Biomaterials for the Treatment of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Biomimetic approach to cardiac tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Renovation of the injured heart with myocardial tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Custom design of the cardiac microenvironment with biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Heart muscle engineering: an update on cardiac muscle replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Current state of the art in myocardial tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Tissue engineering of a differentiated cardiac muscle construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Medium perfusion enables engineering of compact and contractile cardiac tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Tissue engineering of vascularized cardiac muscle from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Microvascular transplantation after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Myocardial restoration with embryonic stem cell bioartificial tissue transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Injectable biopolymers enhance angiogenesis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Theoretical impact of the injection of material into the myocardium: a finite element model simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Biopolymeric delivery matrices for angiogenic growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Local delivery of proteins and the use of self-assembling peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Insulin-like growth factor-1 as a vascular protective factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

G-CSF therapy for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovasc

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Gene and cell therapy for chronic ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure–volume loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

Perfusion Improves Tissue Architecture of Engineered Cardiac Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.5.669

21 January 2018

Identifiers

DOI

10.1586/14779072.6.5.669

1 reference

18 August 2017

1 reference